EUVIMEDEUVIMED entdecken
Open Access

Prevalence and interpretation of Xpert ® Ultra trace results among presumptive TB patients

L Chilukutu, W Mwanza, A D Kerkhoff, P Somwe, M Kagujje, M Muyoyeta

Public Health Action · 2022-03 · 12 (1) · 28-33

DOI: 10.5588/pha.21.0066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Public Health Action, online erschienen am 01.03.2022. Verfasst von L Chilukutu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Infectious Disease Research in Zambia, TB Department, Lusaka Zambia. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The “trace call” results on Xpert® Ultra indicates extremely low TB levels and may be difficult to interpret. The prevalence of trace results among presumptive TB patients in high TB-HIV infection settings is unknown, as is the significance of divergent “trace call” result interpretations. METHODS: Presumptive TB patients attending a public health facility in Lusaka, Zambia, were prospectively enrolled. Participants underwent several TB investigations, including sputum smear microscopy, Ultra testing, and culture. The diagnostic accuracy of Ultra (culture-based reference) and the number of patients recommended for TB treatment was assessed according to several different interpretation criteria for “trace call” results. RESULTS: Among the 740 participants, 78 (10.5%) were Ultra-positive and an additional 37 (5.0%) had a “trace call” result. The prevalence of trace results did not differ according to HIV status (5.3% vs. 4.8%) or prior TB status (5.6% vs. 4.9%). Differing interpretations of trace results had modest effects on Ultra’s sensitivity (range 79.3–82.6%) and specificity (range 94.3–99.2%), but increased the number of patients recommended for treatment by up to 44.9%. CONCLUSIONS: Ultra trace results were common in this setting. The interpretation of trace results may substantially impact TB case yield.

Schlagwörter

Stichwörter der Autor:innen

CADHIVdiagnosistuberculosis

Autor:innen und Institutionen

  • Centre for Infectious Disease Research in Zambia, TB Department, Lusaka Zambia.
  • Division of HIV, Infectious Diseases and Global Medicine Zuckerberg San Francisco General Hospital and Trauma Center University of California, San Francisco, San Francisco, CA, USA.

Zitieren

APA

Chilukutu, L., Mwanza, W., Kerkhoff, A. D., Somwe, P., Kagujje, M., & Muyoyeta, M. (2022). Prevalence and interpretation of Xpert ® Ultra trace results among presumptive TB patients. Public Health Action, 12(1), 28-33. https://doi.org/10.5588/pha.21.0066

Vancouver

Chilukutu L, Mwanza W, Kerkhoff AD, Somwe P, Kagujje M, Muyoyeta M. Prevalence and interpretation of Xpert ® Ultra trace results among presumptive TB patients. Public Health Action. 2022;12(1):28-33. doi:10.5588/pha.21.0066

BibTeX
@article{Chilukutu2022,
  author = {Chilukutu, L and Mwanza, W and Kerkhoff, A D and Somwe, P and Kagujje, M and Muyoyeta, M},
  title = {Prevalence and interpretation of Xpert ® Ultra trace results among presumptive TB patients},
  journal = {Public Health Action},
  year = {2022},
  volume = {12},
  number = {1},
  pages = {28--33},
  doi = {10.5588/pha.21.0066}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche